Severe Malaria Observatory
Knowledge sharing for severe malaria
Search
Search
Search
English
\n
Français
\n
Search
Toggle main menu visibility
Severe malaria
What is malaria?
Global burden
Symptoms
Diagnosis
Treatment
Groups at risk
Countries
Angola
Benin
Burkina Faso
Burundi
Cameroon
Central African Republic
Democratic Republic of Congo
Ethiopia
Ghana
Guinea
India
La Cote d'Ivoire
Madagascar
Malawi
Mali
Mozambique
Niger
Nigeria
Rwanda
Senegal
South Sudan
Tanzania
Uganda
Zambia
Drugs & markets
In the field
Severe Malaria Projects
Interviews
Toolkits & training
Injectable artesunate
Artesunate Rectal Capsules
Additional resources
Resources
News & Events
Events
Newsletter
About us
FAQ
Search
Search
Home
Resources
Severe Malaria Resources
1
Keywords
From
From
Year
-Year
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
To
To
Year
-Year
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Year
- Any -
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2008
2007
2005
1982
1981
Tags
- Any -
AQUAMAT
Acceptability
Age
ArTiMist
Asia
Asymptomatic
BCC
Burden
Burkina Faso
CHW
Cameroon
Case Management
Case definition
Central African Republic
Children
Community
Correct use
Correlation
Counterfit
DRC
Delay
Diagnosis
Disease progression
Economics
Ethiopia
Ghana
Haemolysis
ICCM
Immunity
Injectable artemether
Injectable artesunate
Injectable quinine
M&E
MATIAS
Malawi
Manifestations
Mapping
Mixed infections
Mortality
Mozambique
Nigeria
P. Knowlesi
P. Vivax
PNG
Practice
Pre-referral
Rectal artesunate
Referral
Resistance
Senegal
Severity
Stock
Substandard drugs
Sudan
Supply
Tanzania
Training
Travellers
Treatment
Treatment practices
Uganda
Vietnam
WHO
Zambia
care-seeking
Resource type
- Any -
Article
Cochrane review
Guide
Information note
Manual
Peer-reviewed article
Report
Severe malaria rapid assessment reports
Strategy
Survey results
Source
- Any -
01 Apr 2008
Rho kinase inhibition in severe malaria: thwarting parasite-induced collateral damage to endothelia.
01 Apr 2008
Mannose-binding lectin variant associated with severe malaria in young African children.
01 Mar 2008
Differential antibody responses to Plasmodium falciparum merozoite proteins in Malawian children with severe malaria.
01 Mar 2008
Reduced immune complex binding capacity and increased complement susceptibility of red cells from children with severe malaria-associated anemia.
01 Mar 2008
Reduced immune complex binding capacity and increased complement susceptibility of red cells from children with severe malaria-associated anemia.
01 Mar 2008
Differential antibody responses to Plasmodium falciparum merozoite proteins in Malawian children with severe malaria.
18 Feb 2008
Inhibition of histamine-mediated signaling confers significant protection against severe malaria in mouse models of disease.
18 Feb 2008
Inhibition of histamine-mediated signaling confers significant protection against severe malaria in mouse models of disease.
13 Feb 2008
Pregnancy outcome and placenta pathology in Plasmodium berghei ANKA infected mice reproduce the pathogenesis of severe malaria in pregnant women.
13 Feb 2008
Pregnancy outcome and placenta pathology in Plasmodium berghei ANKA infected mice reproduce the pathogenesis of severe malaria in pregnant women.
01 Feb 2008
Clinical significance of sequestration in adults with severe malaria.
01 Feb 2008
HLA-DRB1*04 allele is associated with severe malaria in northern Ghana.
Pages
« first
‹ previous
…
99
100
101
102
103
104
105
106
107
…
next ›
last »
0
Malaria ministerial conference documents
06 Mar 2024
Malaria Ministerial Conference documents
30 Nov 2023
WHO Malaria Policy Advisory Group (MPAG) meeting report
06 Mar 2024
Yaoundé declaration